Patent · US Active

Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-YL)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one as tor kinase inhibitors

US9975898B2 · kind B2 · utility

0Cited by
43References
46Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 26, 2016
Grant dateMay 22, 2018
Priority date—
Expiry dateOct 26, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to the compound of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.